GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxurion NV (FRA:TG40) » Definitions » Current Deferred Revenue

Oxurion NV (FRA:TG40) Current Deferred Revenue : €0.00 Mil (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Oxurion NV Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Oxurion NV's current deferred revenue for the quarter that ended in Jun. 2024 was €0.00 Mil.

Oxurion NV Current Deferred Revenue Historical Data

The historical data trend for Oxurion NV's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxurion NV Current Deferred Revenue Chart

Oxurion NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Oxurion NV Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oxurion NV Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Oxurion NV's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxurion NV Business Description

Industry
Traded in Other Exchanges
Address
Gaston Geenslaan 1, Leuven, BEL, B-3001
Oxurion NV is a clinical-stage biopharmaceutical company developing next-generation standard-of-care ophthalmic therapies, which are designed to improve and preserve vision in patients with retinal disorders including Geographic Atrophy (GA). The Group's research and development facilities are located in Belgium. The Company is engaged in the development of drugs to treat blindness diseases.

Oxurion NV Headlines

No Headlines